Authors: Meredith, RF Alvarez, RD Partridge, EE Khazaeli, MB Lin, CY Macey, DJ Austin, JM Kilgore, LC Grizzle, WE Schlom, J LoBuglio, AF

Citation: Rf. Meredith et al., Intraperitoneal radioimmunochemotherapy of ovarian cancer: A phase I study, CANC BIO R, 16(4), 2001, pp. 305-315

Authors: Barnes, MN Kilgore, LC

Citation: Mn. Barnes et Lc. Kilgore, Complete surgical staging of early endometrial adenocarcinoma: Optimizing patient outcomes, SEM RAD ONC, 10(1), 2000, pp. 3-7

Authors: Miller, DS Blessing, JA Kilgore, LC Mannel, R Van Le, L

Citation: Ds. Miller et al., Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas - A Gynecologic Oncology Group study, AM J CL ONC, 23(4), 2000, pp. 355-357

Authors: Barnes, MN Roland, PY Straughn, M Kilgore, LC Alvarez, RD Partridge, EE

Citation: Mn. Barnes et al., A comparison of treatment strategies for endometrial adenocarcinoma: Analysis of financial impact, GYNECOL ONC, 74(3), 1999, pp. 443-447

Authors: Naumann, RW Alvarez, RD Omura, GA Segars, E Kilgore, LC Partridge, EE

Citation: Rw. Naumann et al., A phase I study of paclitaxel, doxorubicin, and cisplatin in patients withpreviously untreated epithelial ovarian cancer, GYNECOL ONC, 71(3), 1998, pp. 450-453